E
Elena De Vecchi
Researcher at University of Milan
Publications - 114
Citations - 2694
Elena De Vecchi is an academic researcher from University of Milan. The author has contributed to research in topics: Biofilm & Pseudomonas aeruginosa. The author has an hindex of 27, co-authored 103 publications receiving 2025 citations.
Papers
More filters
Journal ArticleDOI
Probiotics reduce gut microbial translocation and improve adult atopic dermatitis.
Enrico Iemoli,Daria Trabattoni,Serena Parisotto,Linda Borgonovo,Marco Toscano,Giuliano Rizzardini,Mario Clerici,Elena Ricci,Alessandra Fusi,Elena De Vecchi,Stefania Piconi,Lorenzo Drago +11 more
TL;DR: The results suggest that this specific mixture of probiotics (LS01 and BR03 strains) may induce beneficial effects for clinical and immunologic alterations in adult AD.
Journal ArticleDOI
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests.
Federico Cabitza,Andrea Campagner,Davide Ferrari,Chiara Di Resta,Daniele Ceriotti,Eleonora Sabetta,Alessandra Colombini,Elena De Vecchi,Giuseppe Banfi,Massimo Locatelli,Anna Carobene +10 more
TL;DR: ML can be applied to blood tests as both an adjunct and alternative method to rRT-PCR for the fast and cost-effective identification of COVID-19-positive patients in developing countries, or in countries facing an increase in contagions.
Journal ArticleDOI
Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study
Lorenzo Drago,Delia Romanò,Elena De Vecchi,Christian Vassena,Nicola Logoluso,Roberto Mattina,Carlo Luca Romanò +6 more
TL;DR: In vitro and in vivo findings reinforce previous observations on the efficacy of BAG-S53P4 for the treatment of chronic osteomyelitis of the long bones, also in the presence of multi-resistant strains and in immunocompromised hosts, without relevant side effects and without the need for locally adding antibiotics.
Journal ArticleDOI
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections
TL;DR: In vitro evidence of synergy between glycopeptides, fluoroquinolones (levofloxacin) and β-lactams and of reduction of mutational frequencies by combinations are suggestive for a potential role in empirical therapy of severe pneumonia with suspected MRSA etiology.
Journal ArticleDOI
Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study
TL;DR: B. rhamnosus HN001 showed the ability to modulate the gut microbiota composition, leading to a significant reduction of potentially harmful bacteria and an increase of beneficial ones.